British Columbia Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-27,563
| Closed | -$1.49M | – | 701 |
|
|
2025
Q3 | $1.49M | Sell |
27,563
-2,624
| -9% | -$150K | 0.01% | 635 |
|
|
2025
Q2 | $1.66M | Sell |
30,187
-6,251
| -17% | -$368K | 0.01% | 622 |
|
|
2025
Q1 | $2.58M | Sell |
36,438
-10
| -0% | -$673 | 0.02% | 568 |
|
|
2024
Q4 | $2.4M | Buy |
36,448
+4,772
| +15% | +$320K | 0.01% | 594 |
|
|
2024
Q3 | $2.23M | Sell |
31,676
-4,667
| -13% | -$390K | 0.01% | 591 |
|
|
2024
Q2 | $2.99M | Buy |
36,343
+13,853
| +62% | +$1.15M | 0.02% | 516 |
|
|
2024
Q1 | $1.96M | Buy |
22,490
+818
| +4% | +$73.2K | 0.01% | 566 |
|
|
2023
Q4 | $2.09M | Buy |
21,672
+4,601
| +27% | +$407K | 0.02% | 510 |
|
|
2023
Q3 | $1.51M | Buy |
17,071
+159
| +0.9% | +$14.1K | 0.01% | 509 |
|
|
2023
Q2 | $1.47M | Buy |
16,912
+483
| +3% | +$45.5K | 0.01% | 541 |
|
|
2023
Q1 | $1.6M | Hold |
16,429
| – | – | 0.02% | 505 |
|
|
2022
Q4 | $1.7M | Sell |
16,429
-1,876
| -10% | -$176K | 0.02% | 488 |
|
|
2022
Q3 | $1.55M | Sell |
18,305
-2,920
| -14% | -$260K | 0.02% | 514 |
|
|
2022
Q2 | $1.76M | Sell |
21,225
-7,118
| -25% | -$567K | 0.02% | 537 |
|
|
2022
Q1 | $2.19M | Sell |
28,343
-3,837
| -12% | -$321K | 0.01% | 633 |
|
|
2021
Q4 | $2.84M | Sell |
32,180
-1,616
| -5% | -$133K | 0.02% | 609 |
|
|
2021
Q3 | $2.61M | Buy |
33,796
+188
| +0.6% | +$14.8K | 0.02% | 628 |
|
|
2021
Q2 | $2.8M | Buy |
33,608
+3,860
| +13% | +$306K | 0.02% | 625 |
|
|
2021
Q1 | $2.25M | Sell |
29,748
-830
| -3% | -$67.8K | 0.02% | 628 |
|
|
2020
Q4 | $2.68M | Sell |
30,578
-785
| -3% | -$62.2K | 0.02% | 557 |
|
|
2020
Q3 | $2.39M | Buy |
31,363
+2,545
| +9% | +$257K | 0.02% | 537 |
|
|
2020
Q2 | $3.55M | Buy |
28,818
+9,170
| +47% | +$911K | 0.04% | 387 |
|
|
2020
Q1 | $1.66M | Sell |
19,648
-22,641
| -54% | -$1.95M | 0.03% | 420 |
|
|
2019
Q4 | $3.58M | Buy |
42,289
+1,307
| +3% | +$98.7K | 0.03% | 469 |
|
|
2019
Q3 | $2.76M | Sell |
40,982
-9,976
| -20% | -$768K | 0.03% | 491 |
|
|
2019
Q2 | $4.37M | Buy |
50,958
+2,369
| +5% | +$203K | 0.04% | 477 |
|
|
2019
Q1 | $4.32M | Sell |
48,589
-11,600
| -19% | -$1.08M | 0.04% | 466 |
|
|
2018
Q4 | $5.13M | Buy |
60,189
+5,854
| +11% | +$557K | 0.05% | 410 |
|
|
2018
Q3 | $5.27M | Sell |
54,335
-19,770
| -27% | -$1.97M | 0.06% | 381 |
|
|
2018
Q2 | $6.98M | Sell |
74,105
-20,071
| -21% | -$1.76M | 0.06% | 371 |
|
|
2018
Q1 | $7.63M | Sell |
94,176
-23,408
| -20% | -$2.01M | 0.06% | 384 |
|
|
2017
Q4 | $10.5M | Buy |
117,584
+7,517
| +7% | +$654K | 0.07% | 306 |
|
|
2017
Q3 | $10.2M | Buy |
110,067
+3,771
| +4% | +$333K | 0.08% | 297 |
|
|
2017
Q2 | $9.65M | Buy |
106,296
+8,104
| +8% | +$737K | 0.08% | 310 |
|
|
2017
Q1 | $8.62M | Sell |
98,192
-3,621
| -4% | -$322K | 0.07% | 364 |
|
|
2016
Q4 | $8.43M | Buy |
101,813
+13,635
| +15% | +$1.17M | 0.07% | 314 |
|
|
2016
Q3 | $8.16M | Sell |
88,178
-12,725
| -13% | -$1.2M | 0.08% | 291 |
|
|
2016
Q2 | $7.85M | Hold |
100,903
| – | – | 0.07% | 319 |
|
|
2016
Q1 | $8.32M | Buy |
100,903
+4,639
| +5% | +$377K | 0.08% | 297 |
|
|
2015
Q4 | $10.1M | Buy |
96,264
+53,741
| +126% | +$5.61M | 0.1% | 241 |
|
|
2015
Q3 | $4.48M | Buy |
42,523
+11,617
| +38% | +$1.55M | 0.05% | 397 |
|
|
2015
Q2 | $4.23M | Sell |
30,906
-3,501
| -10% | -$434K | 0.04% | 442 |
|
|
2015
Q1 | $4.29M | Sell |
34,407
-19,711
| -36% | -$2.09M | 0.04% | 441 |
|
|
2014
Q4 | $4.89M | Buy |
54,118
+38,513
| +247% | +$3.2M | 0.04% | 424 |
|
|
2014
Q3 | $1.13M | Hold |
15,605
| – | – | 0.01% | 602 |
|
|
2014
Q2 | $971K | Buy |
15,605
+7,174
| +85% | +$433K | 0.01% | 622 |
|
|
2014
Q1 | $575K | Sell |
8,431
-15,657
| -65% | -$1.15M | ﹤0.01% | 661 |
|
|
2013
Q4 | $1.7M | Sell |
24,088
-56,115
| -70% | -$3.81M | 0.01% | 572 |
|
|
2013
Q3 | $5.79M | Buy |
80,203
+69,152
| +626% | +$4.6M | 0.05% | 408 |
|
|
2013
Q2 | $616K | Buy |
+11,051
| New | +$689K | 0.01% | 652 |
|
Other funds holding BMRN
British Columbia Investment Management's BMRN Position: Q4 2025 in Review
British Columbia Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 27,563 shares — an estimated $1.49M sold.
British Columbia Investment Management first reported a position in BMRN in Q2 2013 and held it in 50 quarters. The position peaked at $10.5M in Q4 2017. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.
- British Columbia Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- British Columbia Investment Management sold 27,563 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $1.49M.
- British Columbia Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 50 quarters.
- British Columbia Investment Management's BioMarin Pharmaceuticals position peaked at $10.5M in Q4 2017.
- 539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.
Based on British Columbia Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.